Yusuf A. Haggag

1.5k total citations · 1 hit paper
34 papers, 1.0k citations indexed

About

Yusuf A. Haggag is a scholar working on Biomaterials, Pharmaceutical Science and Molecular Biology. According to data from OpenAlex, Yusuf A. Haggag has authored 34 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Biomaterials, 11 papers in Pharmaceutical Science and 9 papers in Molecular Biology. Recurrent topics in Yusuf A. Haggag's work include Nanoparticle-Based Drug Delivery (9 papers), Advanced Drug Delivery Systems (8 papers) and Drug Solubulity and Delivery Systems (5 papers). Yusuf A. Haggag is often cited by papers focused on Nanoparticle-Based Drug Delivery (9 papers), Advanced Drug Delivery Systems (8 papers) and Drug Solubulity and Delivery Systems (5 papers). Yusuf A. Haggag collaborates with scholars based in Egypt, United Kingdom and United States. Yusuf A. Haggag's co-authors include Ahmed Faheem, Paul A. McCarron, Murtaza M. Tambuwala, Sanaa A. El‐Gizawy, Mohamed El‐Tanani, Kamal Okasha, Nahla E. El‐Ashmawy, Mohammed Osman, Roland Ulber and Ahmed Zayed and has published in prestigious journals such as Scientific Reports, Journal of Controlled Release and International Journal of Pharmaceutics.

In The Last Decade

Yusuf A. Haggag

31 papers receiving 997 citations

Hit Papers

1 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Fucoidan in Pharmaceutical Formulations: A Comprehensive Review for Smart Drug Delivery Systems

2023 71 citations Yusuf A. Haggag, Roland Ulber et al. Marine Drugs profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Yusuf A. Haggag Egypt	21	360	301	200	142	113	34	1.0k
Aun Raza China	23	425 1.2×	356 1.2×	197 1.0×	301 2.1×	104 0.9×	50	1.4k
Vivek K. Pawar India	20	339 0.9×	376 1.2×	556 2.8×	240 1.7×	97 0.9×	39	1.5k
Hani Z. Asfour Saudi Arabia	24	534 1.5×	139 0.5×	191 1.0×	78 0.5×	78 0.7×	82	1.4k
Muhammad H. Sultan Saudi Arabia	20	300 0.8×	308 1.0×	202 1.0×	156 1.1×	40 0.4×	54	1.0k
Massimiliano Pio di Cagno Norway	16	305 0.8×	236 0.8×	578 2.9×	127 0.9×	103 0.9×	33	1.3k
Ahmed Abdrabou Egypt	22	379 1.1×	153 0.5×	64 0.3×	114 0.8×	132 1.2×	90	1.3k
Komal Sharma India	21	514 1.4×	184 0.6×	92 0.5×	106 0.7×	73 0.6×	75	1.2k
Kavit Raval India	10	306 0.8×	299 1.0×	373 1.9×	223 1.6×	55 0.5×	11	1.3k
Raghu Solanki India	16	240 0.7×	250 0.8×	76 0.4×	204 1.4×	67 0.6×	48	832
Mohamed Rahamathulla Saudi Arabia	18	261 0.7×	256 0.9×	297 1.5×	255 1.8×	61 0.5×	66	1.1k

Countries citing papers authored by Yusuf A. Haggag

Since Specialization

Citations

This map shows the geographic impact of Yusuf A. Haggag's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yusuf A. Haggag with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yusuf A. Haggag more than expected).

Fields of papers citing papers by Yusuf A. Haggag

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yusuf A. Haggag. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yusuf A. Haggag. The network helps show where Yusuf A. Haggag may publish in the future.

Co-authorship network of co-authors of Yusuf A. Haggag

This figure shows the co-authorship network connecting the top 25 collaborators of Yusuf A. Haggag. A scholar is included among the top collaborators of Yusuf A. Haggag based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yusuf A. Haggag. Yusuf A. Haggag is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Haggag, Yusuf A., et al.. (2025). Enhanced intestinal permeation of novel sulpiride electrospun nanofibers: formulation, optimization, and ex vivo evaluation of drug absorption. Drug Development and Industrial Pharmacy. 51(4). 295–308. 2 indexed citations

Haggag, Yusuf A., et al.. (2024). Co-delivery of novel valsartan and hydrochlorothiazide pH-responsive electrospun polymeric nanofibers for improved oral delivery. Journal of Drug Delivery Science and Technology. 101. 106241–106241. 4 indexed citations

Haggag, Yusuf A., et al.. (2024). Bioadhesive behaviors of HPMC E5: comparative analysis of various techniques, histological and human radiological evidence. Scientific Reports. 14(1). 1840–1840. 3 indexed citations

Osman, Mohammed, et al.. (2023). Bioavailability enhancement of acyclovir by honey: Analytical and histological evidence. Journal of Drug Delivery Science and Technology. 80. 104155–104155. 1 indexed citations

Haggag, Yusuf A., et al.. (2023). Fucoidan in Pharmaceutical Formulations: A Comprehensive Review for Smart Drug Delivery Systems. Marine Drugs. 21(2). 112–112. 71 indexed citations breakdown →

Haggag, Yusuf A., et al.. (2023). Evaluation of the effect of guanabenz-loaded nanoparticles on chronic toxoplasmosis in mice. Experimental Parasitology. 246. 108460–108460. 2 indexed citations

Salem, Mohamed A., et al.. (2022). Coriander (Coriandrum sativum L.) essential oil and oil-loaded nano-formulations as an anti-aging potentiality via TGFβ/SMAD pathway. Scientific Reports. 12(1). 6578–6578. 43 indexed citations

El‐Tanani, Mohamed, Angela Platt‐Higgins, Yin-Fai Lee, et al.. (2022). Matrix metalloproteinase 2 is a target of the RAN-GTP pathway and mediates migration, invasion and metastasis in human breast cancer. Life Sciences. 310. 121046–121046. 21 indexed citations

Zewail, Moataz B., Sanaa A. El‐Gizawy, Mohammed Osman, & Yusuf A. Haggag. (2021). Preparation and In vitro characterization of a novel self-nano emulsifying drug delivery system for a fixed-dose combination of candesartan cilexetil and hydrochlorothiazide. Journal of Drug Delivery Science and Technology. 61. 102320–102320. 41 indexed citations

10.

Haggag, Yusuf A., et al.. (2020). <p>Design, Formulation and in vivo Evaluation of Novel Honokiol-Loaded PEGylated PLGA Nanocapsules for Treatment of Breast Cancer</p>. International Journal of Nanomedicine. Volume 15. 1625–1642. 59 indexed citations

11.

El‐Ashmawy, Nahla E., Kamal Okasha, Tarek M. Mostafa, et al.. (2020). The plausible mechanisms of tramadol for treatment of COVID-19. Medical Hypotheses. 146. 110468–110468. 20 indexed citations

12.

Haggag, Yusuf A., Nahla E. El‐Ashmawy, & Kamal Okasha. (2020). Is hesperidin essential for prophylaxis and treatment of COVID-19 Infection?. Medical Hypotheses. 144. 109957–109957. 93 indexed citations

13.

Haggag, Yusuf A., et al.. (2020). Co-delivery of a RanGTP inhibitory peptide and doxorubicin using dual-loaded liposomal carriers to combat chemotherapeutic resistance in breast cancer cells. Expert Opinion on Drug Delivery. 17(11). 1655–1669. 55 indexed citations

14.

Haggag, Yusuf A., et al.. (2020). Nanoencapsulation of sophorolipids in PEGylated poly(lactide-co-glycolide) as a novel approach to target colon carcinoma in the murine model. Drug Delivery and Translational Research. 10(5). 1353–1366. 32 indexed citations

15.

Haggag, Yusuf A., Mohammed Osman, Sanaa A. El‐Gizawy, et al.. (2018). Polymeric nano-encapsulation of 5-fluorouracil enhances anti-cancer activity and ameliorates side effects in solid Ehrlich Carcinoma-bearing mice. Biomedicine & Pharmacotherapy. 105. 215–224. 46 indexed citations

16.

Haggag, Yusuf A., Kyle B. Matchett, Paul Buchanan, et al.. (2017). Nano-encapsulation of a novel anti-Ran-GTPase peptide for blockade of regulator of chromosome condensation 1 (RCC1) function in MDA-MB-231 breast cancer cells. International Journal of Pharmaceutics. 521(1-2). 40–53. 44 indexed citations

17.

Haggag, Yusuf A., et al.. (2017). Polymeric Nano-Encapsulation of Curcumin Enhances its Anti-Cancer Activity in Breast (MDA-MB231) and Lung (A549) Cancer Cells Through Reduction in Expression of HIF-1α and Nuclear p65 (Rel A). Current Drug Delivery. 15(2). 286–295. 54 indexed citations

18.

Haggag, Yusuf A., et al.. (2016). Sulindac solid dispersions: development, characterization and in vivo evaluation of ulcerogenic activity in rats. Journal of Applied Pharmaceutical Science. 22–31. 2 indexed citations

19.

Haggag, Yusuf A. & Ahmed Faheem. (2015). Evaluation of nano spray drying as a method for drying and formulation of therapeutic peptides and proteins. Frontiers in Pharmacology. 6. 140–140. 66 indexed citations

20.

Haggag, Yusuf A., Yasser H.A. Abdel‐Wahab, Opeolu O. Ojo, et al.. (2015). Preparation and in vivo evaluation of insulin-loaded biodegradable nanoparticles prepared from diblock copolymers of PLGA and PEG. International Journal of Pharmaceutics. 499(1-2). 236–246. 71 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact